Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongge Liu

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Handbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterases as targets for intermittent claudicationYongge Liu, Yasmin Shakur, Junichi Kambayashi
Platelets|June 19, 2004
Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamoleShosaku Nomura, Norihito Inami, Toshiji Iwasaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 8, 2009
Cilostazol increases tissue blood flow in contracting rabbit gastrocnemius muscleMiranda Fong, Masuhiro Yoshitake, Junichi Kambayashi, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2023
Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo ExperimentsYongge Liu, Mischka Moodley, Jotam G Pasipanodya, et al.
The Analyst|June 16, 2023
Ultrasensitive detection of CA125 based on a triple signal amplification strategy with a huge number of loaded probes <i>via</i> exonuclease cyclic cleavage, rolling cyclic amplification and strand self-growthLi He, Ciping Chen, Yongge Liu, et al.
Tuberculosis (Edinburgh, Scotland)|April 5, 2018
Corrigendum to "Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis" [Tuberculosis 108 (January 2018) 186-194]Mamoru Fujiwara, Masanori Kawasaki, Norimitsu Hariguchi, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosisMamoru Fujiwara, Masanori Kawasaki, Norimitsu Hariguchi, et al.
Cardiovascular Drugs and Therapy|May 11, 2005
Antiplatelet and antithrombotic activity of cilostazol is potentiated by dipyridamole in rabbits and dissociated from bleeding time prolongationHaiquan Li, James Cone, Miranda Fong, et al.
Current Pharmaceutical Design|October 8, 2003
Cilostazol as a unique antithrombotic agentJunichi Kambayashi, Yongge Liu, Bing Sun, et al.
Plos One|April 30, 2024
A simple and effective convolutional operator for node classification without features by graph convolutional networksQingju Jiao, Han Zhang, Jingwen Wu, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Handbook of Experimental Pharmacology|June 23, 2011
Phosphodiesterases as targets for intermittent claudicationYongge Liu, Yasmin Shakur, Junichi Kambayashi
Platelets|June 19, 2004
Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamoleShosaku Nomura, Norihito Inami, Toshiji Iwasaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 8, 2009
Cilostazol increases tissue blood flow in contracting rabbit gastrocnemius muscleMiranda Fong, Masuhiro Yoshitake, Junichi Kambayashi, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2023
Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo ExperimentsYongge Liu, Mischka Moodley, Jotam G Pasipanodya, et al.
The Analyst|June 16, 2023
Ultrasensitive detection of CA125 based on a triple signal amplification strategy with a huge number of loaded probes <i>via</i> exonuclease cyclic cleavage, rolling cyclic amplification and strand self-growthLi He, Ciping Chen, Yongge Liu, et al.
Tuberculosis (Edinburgh, Scotland)|April 5, 2018
Corrigendum to "Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis" [Tuberculosis 108 (January 2018) 186-194]Mamoru Fujiwara, Masanori Kawasaki, Norimitsu Hariguchi, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosisMamoru Fujiwara, Masanori Kawasaki, Norimitsu Hariguchi, et al.
Cardiovascular Drugs and Therapy|May 11, 2005
Antiplatelet and antithrombotic activity of cilostazol is potentiated by dipyridamole in rabbits and dissociated from bleeding time prolongationHaiquan Li, James Cone, Miranda Fong, et al.
Current Pharmaceutical Design|October 8, 2003
Cilostazol as a unique antithrombotic agentJunichi Kambayashi, Yongge Liu, Bing Sun, et al.
Plos One|April 30, 2024
A simple and effective convolutional operator for node classification without features by graph convolutional networksQingju Jiao, Han Zhang, Jingwen Wu, et al.
Pageof 4